1. General Resources
Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings
​
Guide to Medication for Treating Alcohol Use Disorder
​
SAMHSA TIP 35: Enhancing Motivation for Change in SUD Treatment SAMHSA TIP 35
​
Evidence Based Resource Guide on Treatment of Stimulant Use Disorder
​
Nevada DPBH Overdose Prevention
​
ATTC Educational Packages for OUD
​
AHRQ Integration Academy Substance Use Resources
​
Nevada State Opioid Response (SOR)
​
Nevada Controlled Substance Abuse Prevention Act (AB 474)
​
AB474 Toolkit - Nevada State Medical Association
​
Medications for Opioid Use Disorder Save Lives
​
Medication for the Treatment of Alcohol Use Disorder
​
Enhancing Motivation for Change in Substance Use Disorder Treatment
Treatment of Stimulant Use Disorders - Evidence-Based Resource Guide Series
​
Executive Summary Medications for Opioid Use Disorder
​
Medications for Opioid Use Disorder
​
Primary Care-Based Models for OUD
​
Standard Framework for Levels of Integrated Care
​
How to Become a Buprenorphine Waivered Practitioner to treat OUD
-
New Buprenorphine Practice Guidelines, Expanding Access to Treatment for Opioid Use Disorder - HHS
-
FAQs About the New Buprenorphine Practice Guidelines - SAMHSA
X-Waiver Training - Providers Clinical Support System (PCSS)​
​
2. Planning Documents
3. Sample Workflows & Templates
MSHC MAT Sample Workflow Program Design - Patient Phases
​
Suboxone/buprenorphine Therapy Progress Report
​
Epic “Dot Phrases” for Substance Use Navigators
​
​
MSHC Sample MAT Workflow for Referral
​
MSHC MAT Sample Workflow Program Design
​
Buprenorphine Home Initiation vs Office Initiation Considerations
​
4. Patient Treatment
Agreements
5. Confidentiality Considerations for Primary Care
7. Sample Protocols, Procedures, & Policies
Elements of an OBOT Diversion Control Plan
​
SAMHSA Diversion Control Protocol
​
​
How to Prepare for a DEA Inspection
​
Guidance on Billing for Office-Based Treatment of OUD
​
Billing and Coding: Medication Assisted Treatment
​
Navigator and Clinician Champion Collaboration
​
​
Elements of an OBOT Diversion Control Plan
​
SAMHSA Diversion Control Protocol
​
​
How to Prepare for a DEA Inspection
​
Heartland Sample Urine Drug Testing
​
Heartland Sample Late Arrival Policy
​
Heartland Sample Referral Protocol
​
MSHC Sample Policy Sanctions and Incentives
​
BMC Sample Urine Toxicology Policy
​
BMC Sample Lost, Stolen, or Destroyed Buprenorphine Policy
​
9. Harm Reduction Resources
6. Clinical Tools
DSM-5 Criteria for Diagnosis of OUD
​
Clinical Opiate Withdrawal Scale
​
​
​
​
ASAM Drug Testing Pocket Guide
​
Naloxone Distribution in Nevada
​
Patient Counseling Tool for XR Naltrexone
​
Reducing Naltrexone Injection Site Reactions
​
Treating Pregnant and Postpartum Women and Infants
​
Opioid Use, Misuse, and Overdose in Women
​
Provider Clinical Support System (PCSS)
​
ED Bridge - Emergency Dept. Initiation of MOUD
​
8. Patient Education
10. EHR Resources
11. Quality Assurance and Peer Review Tools
13. OUD Treatment in Patients with HIV or Hepatitis
12. OUD Treatment for Women & Newborns
Consensus Statement on Obstetric Care for Women with OUD
​
Patient Factsheet - OUD Treatment for Pregnant and Post-Natal Women
​
Patient Factsheet - OUD Treatment during Pregnancy
​
Patient Factsheet - NAS Treatment
​
Patient Factsheet - Intro to OUD Treatment during Pregnancy
​
Summary of Literature on Treating Pregnant Women, Parents and their Children
​
Treatment recommendations and algorithms for HCV
​
Drug interactions in the treatment of HCV
Drug interactions in the treatment of HIV
Nevada Medicaid Hepatitis C Agents Prior Authorization Request Form
Southern Nevada Health District Hepatitis C Patient Clinics and Resources
​
Nevada Statewide Hepatitis Resource Directory
​
Concurrent Treatment of HIV and OUD
​
Considerations for MAT in Patients with HIV
​